Skip to main content

Squarepoint Ops LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1642575 NEW YORK, NY

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
449,796
+134.1% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
27,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 449,796
2025-12-31 192,156
2025-09-30 52,834
2025-09-30 27,000
2025-06-30 329,392
2025-03-31 442,793
2024-12-31 166,962
2024-09-30 90,341
2024-06-30 61,258
2023-12-31 15,000
2023-12-31 15,000
2022-09-30 101,085
2022-06-30 50,380
2022-03-31 19,298
2021-06-30 5,344
2020-09-30 26,422
2020-06-30 22,790
2020-03-31 9,991